Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in EOLS — Evolus, Inc.

CIK 1107261 HOUSTON, TX
Back to EOLS Full portfolio

Position in EOLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$173,500
-$1,238,240 QoQ
Shares Held
25,000
-77.6% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 158 holders
Holding Since
Dec 2020
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $34,784,557 across 16 Drug Manufacturers - Specialty & Generic names. EOLS ranks #13 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PCRX
Pacira BioSciences, Inc.
 411,373 $10,436,533
2 PRGO
PERRIGO Co plc
 830,134 $8,625,092
3 AMPH
Amphastar Pharmaceuticals, Inc.
 298,954 $6,032,891
4 AMRX
Amneal Pharmaceuticals, Inc.
 106,449 $1,842,632
5 IRWD
Ironwood Pharmaceuticals Inc
 389,793 $1,641,028
6 INDV
Indivior Pharmaceuticals, Inc.
 35,000 $1,436,050
7 UTHR
UNITED THERAPEUTICS Corp
 2,620 $1,419,594
8 BIOA
BioAge Labs, Inc.
 42,000 $1,029,420

All Filings in EOLS

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $173,500 25,000
2021-06-30 $1,411,740 111,600
2021-03-31 $1,774,434 136,600
2020-12-31 $458,976 136,600